WO2009001764A1 - 統合失調症の治療または予防剤 - Google Patents
統合失調症の治療または予防剤 Download PDFInfo
- Publication number
- WO2009001764A1 WO2009001764A1 PCT/JP2008/061309 JP2008061309W WO2009001764A1 WO 2009001764 A1 WO2009001764 A1 WO 2009001764A1 JP 2008061309 W JP2008061309 W JP 2008061309W WO 2009001764 A1 WO2009001764 A1 WO 2009001764A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- dysfunction syndrome
- remedy
- preventive
- integration dysfunction
- integration
- Prior art date
Links
- 208000011580 syndromic disease Diseases 0.000 title abstract 6
- 230000004064 dysfunction Effects 0.000 title abstract 5
- 230000010354 integration Effects 0.000 title abstract 5
- 230000003449 preventive effect Effects 0.000 title abstract 3
- 239000002253 acid Substances 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 208000010877 cognitive disease Diseases 0.000 abstract 1
- 229940125904 compound 1 Drugs 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 230000010365 information processing Effects 0.000 abstract 1
- INAXVFBXDYWQFN-XHSDSOJGSA-N morphinan Chemical group C1C2=CC=CC=C2[C@]23CCCC[C@H]3[C@@H]1NCC2 INAXVFBXDYWQFN-XHSDSOJGSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
- C07D489/08—Oxygen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
Abstract
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL08777453T PL2168580T3 (pl) | 2007-06-22 | 2008-06-20 | Środek do leczenia lub zapobiegania schizofrenii |
EP08777453.5A EP2168580B1 (en) | 2007-06-22 | 2008-06-20 | Remedy or preventive for schizophrenia |
CA2691220A CA2691220C (en) | 2007-06-22 | 2008-06-20 | Remedy or preventive for integration dysfunction syndrome |
AU2008268202A AU2008268202B2 (en) | 2007-06-22 | 2008-06-20 | Remedy or preventive for integration dysfunction syndrome |
US12/664,686 US8183256B2 (en) | 2007-06-22 | 2008-06-20 | Remedy or preventive for integration dysfunction syndrome |
CN2008801034116A CN101778632B (zh) | 2007-06-22 | 2008-06-20 | 综合失调症的治疗或预防药 |
JP2009520550A JP5343848B2 (ja) | 2007-06-22 | 2008-06-20 | 統合失調症の治療または予防剤 |
ES08777453.5T ES2555785T3 (es) | 2007-06-22 | 2008-06-20 | Remedio o preventivo para esquizofrenia |
KR20097026917A KR101492029B1 (ko) | 2007-06-22 | 2008-06-20 | 통합 실조증의 치료 또는 예방제 |
MX2009014181A MX2009014181A (es) | 2007-06-22 | 2008-06-20 | Remedio o preventivo para sindrome de disfuncion de integracion. |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007-164868 | 2007-06-22 | ||
JP2007164868 | 2007-06-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2009001764A1 true WO2009001764A1 (ja) | 2008-12-31 |
Family
ID=40185582
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2008/061309 WO2009001764A1 (ja) | 2007-06-22 | 2008-06-20 | 統合失調症の治療または予防剤 |
Country Status (11)
Country | Link |
---|---|
US (1) | US8183256B2 (ja) |
EP (1) | EP2168580B1 (ja) |
JP (1) | JP5343848B2 (ja) |
KR (1) | KR101492029B1 (ja) |
CN (1) | CN101778632B (ja) |
AU (1) | AU2008268202B2 (ja) |
CA (1) | CA2691220C (ja) |
ES (1) | ES2555785T3 (ja) |
MX (1) | MX2009014181A (ja) |
PL (1) | PL2168580T3 (ja) |
WO (1) | WO2009001764A1 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011093441A1 (ja) | 2010-01-29 | 2011-08-04 | 東レ株式会社 | 胆道疾患の治療又は予防剤 |
WO2012105475A1 (ja) | 2011-01-31 | 2012-08-09 | 東レ株式会社 | 悪液質の治療又は予防剤 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI449704B (zh) * | 2013-04-26 | 2014-08-21 | Everlight Chem Ind Corp | 嗎啡喃衍生物之結晶、其製造方法、及使用其之醫藥組成物 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999011289A1 (fr) * | 1997-09-02 | 1999-03-11 | Toray Industries, Inc. | Remedes contre la toxicomanie |
JP2000169476A (ja) * | 1998-12-09 | 2000-06-20 | Banyu Pharmaceut Co Ltd | 4−オキソイミダゾリジン−5−スピロ−含窒素複素環式化合物 |
WO2005085228A1 (ja) * | 2004-03-05 | 2005-09-15 | Banyu Pharmaceutical Co., Ltd. | シクロアルカノピリジン誘導体 |
JP2005289886A (ja) * | 2004-03-31 | 2005-10-20 | Satoko Sawaguchi | 自傷行動抑制薬 |
WO2007037513A1 (ja) * | 2005-09-30 | 2007-04-05 | Banyu Pharmaceutical Co., Ltd. | アリール置換含窒素複素環化合物 |
WO2007100775A2 (en) * | 2006-02-27 | 2007-09-07 | Alexander Michalow | Methods for regulating neurotransmitter systems by inducing counteradaptations |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01149788A (ja) | 1987-12-08 | 1989-06-12 | Chugai Pharmaceut Co Ltd | 新規なモルヒネ誘導体 |
DE69321525T2 (de) | 1992-01-23 | 1999-03-04 | Toray Industries | Morphinan-derivate und medizinische verwendung |
DE69413933T2 (de) * | 1993-06-30 | 1999-04-08 | Toray Industries | Antitussiva |
EP0661283B1 (en) | 1993-07-19 | 1998-10-21 | Toray Industries, Inc. | Brain cell protective |
CN1291717C (zh) | 1996-11-25 | 2006-12-27 | 东丽株式会社 | 止痒药物 |
AU6117298A (en) | 1997-07-25 | 1999-02-16 | Toray Industries, Inc. | Hyponatremia remedies |
JPH1192376A (ja) * | 1997-09-17 | 1999-04-06 | Toray Ind Inc | ニコチン依存症治療剤 |
JP2000053572A (ja) | 1998-08-11 | 2000-02-22 | Toray Ind Inc | ORL1(opioid orphan)受容体拮抗薬 |
US6476208B1 (en) * | 1998-10-13 | 2002-11-05 | Genset | Schizophrenia associated genes, proteins and biallelic markers |
JP4867123B2 (ja) | 1999-08-24 | 2012-02-01 | 東レ株式会社 | 神経因性疼痛治療剤および神経因性疼痛のモデル動物 |
PT1380306E (pt) | 2001-03-30 | 2009-05-25 | Toray Industries | Medicamentos para psiconeurose |
US7652025B2 (en) | 2001-05-08 | 2010-01-26 | Toray Industries, Inc. | Remedies for sepsis |
US7553908B1 (en) * | 2003-01-30 | 2009-06-30 | Prc Desoto International, Inc. | Preformed compositions in shaped form comprising polymer blends |
AU2005286733B2 (en) * | 2004-09-23 | 2009-11-05 | Alexander Michalow | Methods for regulating neurotransmitter systems by inducing counteradaptations |
CN101137658B (zh) | 2005-03-10 | 2011-06-08 | 东丽株式会社 | 用于与多发性硬化症伴随的搔痒的止痒剂 |
-
2008
- 2008-06-20 EP EP08777453.5A patent/EP2168580B1/en not_active Not-in-force
- 2008-06-20 AU AU2008268202A patent/AU2008268202B2/en not_active Ceased
- 2008-06-20 CA CA2691220A patent/CA2691220C/en not_active Expired - Fee Related
- 2008-06-20 WO PCT/JP2008/061309 patent/WO2009001764A1/ja active Application Filing
- 2008-06-20 JP JP2009520550A patent/JP5343848B2/ja not_active Expired - Fee Related
- 2008-06-20 CN CN2008801034116A patent/CN101778632B/zh not_active Expired - Fee Related
- 2008-06-20 US US12/664,686 patent/US8183256B2/en active Active
- 2008-06-20 MX MX2009014181A patent/MX2009014181A/es active IP Right Grant
- 2008-06-20 ES ES08777453.5T patent/ES2555785T3/es active Active
- 2008-06-20 PL PL08777453T patent/PL2168580T3/pl unknown
- 2008-06-20 KR KR20097026917A patent/KR101492029B1/ko active IP Right Grant
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999011289A1 (fr) * | 1997-09-02 | 1999-03-11 | Toray Industries, Inc. | Remedes contre la toxicomanie |
JP2000169476A (ja) * | 1998-12-09 | 2000-06-20 | Banyu Pharmaceut Co Ltd | 4−オキソイミダゾリジン−5−スピロ−含窒素複素環式化合物 |
WO2005085228A1 (ja) * | 2004-03-05 | 2005-09-15 | Banyu Pharmaceutical Co., Ltd. | シクロアルカノピリジン誘導体 |
JP2005289886A (ja) * | 2004-03-31 | 2005-10-20 | Satoko Sawaguchi | 自傷行動抑制薬 |
WO2007037513A1 (ja) * | 2005-09-30 | 2007-04-05 | Banyu Pharmaceutical Co., Ltd. | アリール置換含窒素複素環化合物 |
WO2007100775A2 (en) * | 2006-02-27 | 2007-09-07 | Alexander Michalow | Methods for regulating neurotransmitter systems by inducing counteradaptations |
Non-Patent Citations (4)
Title |
---|
GAGLIARDI S. ET AL.: "Morphinan derivatives-A review of the recent patent literature", IDRUGS, vol. 6, no. 2, 2003, pages 129 - 137, XP008126753 * |
IZENWASSER S. ET AL.: "Characterization of kappa-opioid receptor binding in human insular cortex", LIFE SCIENCES, vol. 65, no. 9, 1999, pages 857 - 862, XP008126754 * |
MARGOLIS E.B. ET AL.: "Kappa opioids selectively control dopaminergic Neurons projecting to the prefrontal cortex", PNAS, vol. 103, no. 8, 21 February 2006 (2006-02-21), pages 2938 - 2942, XP008126746 * |
TANAKA C. AND KATO R.: "NEW Yakurigaku, revised 3rd edition", 25 November 1996, NANKODO CO., LTD., pages: 268 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011093441A1 (ja) | 2010-01-29 | 2011-08-04 | 東レ株式会社 | 胆道疾患の治療又は予防剤 |
US10131672B2 (en) | 2010-01-29 | 2018-11-20 | Toray Industries, Inc. | Therapeutic or prophylactic agent for biliary diseases |
WO2012105475A1 (ja) | 2011-01-31 | 2012-08-09 | 東レ株式会社 | 悪液質の治療又は予防剤 |
US9006262B2 (en) | 2011-01-31 | 2015-04-14 | Toray Industries, Inc. | Therapeutic or prophylactic agent for cachexia |
Also Published As
Publication number | Publication date |
---|---|
CN101778632B (zh) | 2012-02-29 |
US20100160364A1 (en) | 2010-06-24 |
CN101778632A (zh) | 2010-07-14 |
KR101492029B1 (ko) | 2015-02-10 |
AU2008268202A1 (en) | 2008-12-31 |
ES2555785T3 (es) | 2016-01-08 |
KR20100023001A (ko) | 2010-03-03 |
PL2168580T3 (pl) | 2016-06-30 |
EP2168580A1 (en) | 2010-03-31 |
EP2168580B1 (en) | 2015-12-02 |
CA2691220C (en) | 2015-05-05 |
EP2168580A4 (en) | 2011-08-17 |
JPWO2009001764A1 (ja) | 2010-08-26 |
CA2691220A1 (en) | 2008-12-31 |
MX2009014181A (es) | 2010-03-04 |
US8183256B2 (en) | 2012-05-22 |
AU2008268202B2 (en) | 2012-12-20 |
JP5343848B2 (ja) | 2013-11-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2014049610A3 (en) | Peptides as gip, glp-1 and glucagon receptors triple-agonist | |
WO2007149797A3 (en) | Use of organic compounds | |
WO2009064460A3 (en) | Gastrointestinal delivery systems | |
WO2011012816A3 (fr) | Formulation pharmaceutique | |
TW200728307A (en) | Novel spirochromanone derivatives | |
WO2008001195A3 (en) | Novel processes for the preparation of dpp iv inhibitors | |
CR10458A (es) | Compuestos de triazolopirazina utiles para el tratamiento de enfermedades degenerativas e inflamatorias | |
CR20110092A (es) | Nuevos compuestos utiles para el tratamiento de enfermedades degenerativas e inflamatorias | |
WO2007087441A3 (en) | Substituted aromatic compounds for inflammation and immune-related uses | |
WO2011041461A3 (en) | Polycyclic compounds as lysophosphatidic acid receptor antagonists | |
WO2008044243A3 (en) | Novel process for the preparation of statins and their pharmaceutically acceptable salts thereof | |
WO2009098715A3 (en) | Novel pyrazolo [3, 4 -d] pyrimidine derivatives as anti -cancer agents | |
WO2007138472A3 (en) | Triazolopyridazine derivatives | |
WO2008094992A3 (en) | 2-aminopyridine derivatives useful as kinase inhibitors | |
WO2006124447A3 (en) | Substituted n-arylpyrrolidines as selective androgen receptor modulators | |
WO2011011882A8 (en) | Hydroxy fatty acid compounds and uses thereof for disease treatment and diagnosis | |
WO2018151861A8 (en) | Methods of treating schizophrenia | |
CR9347A (es) | Derivados de pirimidina para el tratamiento de trastornos hiperproliferativos | |
WO2008143240A1 (ja) | 特定の有機酸を含有する経口製剤並びに経口製剤の溶出性及び化学的安定性の改善方法 | |
WO2011005811A8 (en) | Combination therapy for the treatment of diabetes | |
WO2006074226A3 (en) | Prevention of thrombotic disorders with active vitamin d compounds or mimics thereof | |
WO2007109230A3 (en) | Nutrient compositions for the treatment and prevention of inflammation and disorders associated therewith | |
WO2009016498A8 (en) | Pyrimidine and pyridine derivatives and their pharmaceutical use and compositions | |
MX2009003125A (es) | Tiazol pirazolopirimidinas como antagonistas de receptor de crf1. | |
WO2008048589A3 (en) | Compounds and methods for treatment of hcv |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200880103411.6 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08777453 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009520550 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008268202 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2691220 Country of ref document: CA Ref document number: 2008777453 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: MX/A/2009/014181 Country of ref document: MX |
|
ENP | Entry into the national phase |
Ref document number: 20097026917 Country of ref document: KR Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12664686 Country of ref document: US |
|
ENP | Entry into the national phase |
Ref document number: 2008268202 Country of ref document: AU Date of ref document: 20080620 Kind code of ref document: A |